672 related articles for article (PubMed ID: 29065362)
1. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress.
Surkin PN; Gallino SL; Luce V; Correa F; Fernandez-Solari J; De Laurentiis A
Psychoneuroendocrinology; 2018 Jan; 87():131-140. PubMed ID: 29065362
[TBL] [Abstract][Full Text] [Related]
2. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB
Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634
[TBL] [Abstract][Full Text] [Related]
3. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis.
Navarria A; Tamburella A; Iannotti FA; Micale V; Camillieri G; Gozzo L; Verde R; Imperatore R; Leggio GM; Drago F; Di Marzo V
Pharmacol Res; 2014 Sep; 87():151-9. PubMed ID: 24861565
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.
Hong S; Fan J; Kemmerer ES; Evans S; Li Y; Wiley JW
Gut; 2009 Feb; 58(2):202-10. PubMed ID: 18936104
[TBL] [Abstract][Full Text] [Related]
5. Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation.
Newsom RJ; Garcia RJ; Stafford J; Osterlund C; O'Neill CE; Day HEW; Campeau S
Psychoneuroendocrinology; 2020 Mar; 113():104549. PubMed ID: 31884322
[TBL] [Abstract][Full Text] [Related]
6. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
7. Neurobiological Interactions Between Stress and the Endocannabinoid System.
Morena M; Patel S; Bains JS; Hill MN
Neuropsychopharmacology; 2016 Jan; 41(1):80-102. PubMed ID: 26068727
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats.
Boero G; Pisu MG; Biggio F; Muredda L; Carta G; Banni S; Paci E; Follesa P; Concas A; Porcu P; Serra M
Neuropharmacology; 2018 May; 133():242-253. PubMed ID: 29407214
[TBL] [Abstract][Full Text] [Related]
9. Chronic stress adaptation of the nitric oxide synthases and IL-1β levels in brain structures and hypothalamic-pituitary-adrenal axis activity induced by homotypic stress.
Gadek-Michalska A; Tadeusz J; Rachwalska P; Bugajski J
J Physiol Pharmacol; 2015 Jun; 66(3):427-40. PubMed ID: 26084225
[TBL] [Abstract][Full Text] [Related]
10. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
11. Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo V; De Petrocellis L
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
[TBL] [Abstract][Full Text] [Related]
13. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
14. Sperm Release From the Oviductal Epithelium Depends on Ca(2+) Influx Upon Activation of CB1 and TRPV1 by Anandamide.
Gervasi MG; Osycka-Salut C; Sanchez T; Alonso CA; Llados C; Castellano L; Franchi AM; Villalón M; Perez-Martinez S
J Cell Biochem; 2016 Feb; 117(2):320-33. PubMed ID: 26129689
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.
Patel S; Roelke CT; Rademacher DJ; Cullinan WE; Hillard CJ
Endocrinology; 2004 Dec; 145(12):5431-8. PubMed ID: 15331569
[TBL] [Abstract][Full Text] [Related]
16. Integration of endocannabinoid signaling into the neural network regulating stress-induced activation of the hypothalamic-pituitary-adrenal axis.
Gorzalka BB; Hill MN
Curr Top Behav Neurosci; 2009; 1():289-306. PubMed ID: 21104389
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions.
McLaughlin RJ; Verlezza S; Gray JM; Hill MN; Walker CD
Stress; 2016; 19(1):114-24. PubMed ID: 26552023
[TBL] [Abstract][Full Text] [Related]
18. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
Wenger T; Ledent C; Tramu G
Neuroendocrinology; 2003 Dec; 78(6):294-300. PubMed ID: 14688442
[TBL] [Abstract][Full Text] [Related]
19. Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress.
Rabasa C; Pastor-Ciurana J; Delgado-Morales R; Gómez-Román A; Carrasco J; Gagliano H; García-Gutiérrez MS; Manzanares J; Armario A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1248-59. PubMed ID: 26092203
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.
Newsom RJ; Osterlund C; Masini CV; Day HE; Spencer RL; Campeau S
Neuroscience; 2012 Mar; 204():64-73. PubMed ID: 22138156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
